Abnormal fatty acid metabolism and availability are landmarks of metabolic diseases, which in turn are associated with aberrant DNA methylation profiles. To understand the role of fatty acids in disease epigenetics, we sought DNA methylation profiles 
Introduction
An organism's fatty acid (FA) pool reflects both composition of the diet and endogenous synthesis. Furthermore, abnormal FA levels have long been recognized to participate in metabolic diseases such as diabetes. 1 Since metabolic diseases are frequently associated with aberrant DNA methylation profiles 2 , it is conceivable that FAs are among factors that mediate remodeling of the epigenome in response to dietary composition, the cell's metabolic status and pathogenic signals. In humans, only a handful of studies have investigated a link between DNA methylation and fat intake, focusing on specific genes associated with FA metabolism, inflammation and regulation of circadian rhythms. [3] [4] [5] [6] [7] [8] Furthermore, a recent genome-wide study comparing peripheral whole blood methylation profiles to both quantity and quality of dietary fat intake in adolescents, found a larger number of methylation changes associated with the latter. 9 In that study, DNA methylation profiles associated with polyunsaturated:saturated FA ratio were related to pathways regulated by the peroxisome proliferator-activated receptor  (PPAR-) and adipogenesis. Conversely, no pathways were identified of DNA methylation profiles associated with the monounsaturated:saturated FA ratio. In addition, numerous mouse model studies have addressed short and long term epigenetic effects of diets containing variable combinations of specific FAs. 8, 10 Although diet-based studies are important as they recognize the complexity of the organism's response to nutrients, mechanistic insights can be gained by a simplified complementary approach based on the manipulation of individual FA levels.
Accordingly, the effects of short FAs, such as butyrate, on DNA methylation have been long recognized. 11 In addition, very low-density lipoprotein (VLDL) elicited a global DNA hypermethylation response that is markedly stronger than the one induced by low-or high-density lipoprotein in cultured human THP-1 macrophages. 12, 13 The fact that VLDL is characteristically rich in triglycerides suggests that FAs might be mediators of the epigenetic responses to VLDL. Accordingly, arachidonic acid (AA) induces DNA hypomethylation in human umbilical vein endothelial cells at 3 μM concentration, globally and of angiogenesis regulator kinase insert domain receptor gene promoter. 14, 15 Another study demonstrated that 100 μM eicosapentaenoic acid (EPA) directly modifies the methylation status of CCAAT / enhancer-binding protein delta gene. 16 As for cellular disease models, palmitic acid (PA) was shown to induce global DNA hypermethylation in primary human myocytes and ex vivo human pancreatic islet cells at a 500 μM and 1 mM dose, respectively, affecting targets such as the PPAR- co-activator 1A gene. 17, 18 Furthermore, a recent study in a cellular model of hepatic cancer has shown that a mixture of oleic acid (OA) and PA elicits hypermethylation of selected imprinted gene promoters. 19 Possible mechanisms of epigenetic regulation by
FAs include binding to PPARs, a family of transcription factors that regulate numerous metabolic processes via ligand-dependent transcriptional activation and repression. 20, 21 Currently, it is unknown whether the above-described epigenetic effects are FAspecific, as is the contribution of FAs to disease-related methylation profiles. To understand those issues, we focused on the two long-chain unsaturated FAs, OA and AA, which are known to exert generally opposite cellular inflammatory responses. [22] [23] [24] We studied the effects of these particular FAs on the epigenome and transcriptome of THP-1 cells, a widely accepted human monocyte model 25 , and compared our results to available DNA methylation data of several human diseases and normal tissues. The implications of our results are discussed in the context of current knowledge of epigenetic regulation by lipid components and dietary factors, and their contribution to disease risk.
Results

Effects of the pure AA and OA on global DNA methylation in cultured cells
We first examined the effects of the pure FAs, AA, and OA, on global DNA methylation,
i.e., total normalized 5mdC content in cultured human THP-1 monocytes. Stimulation experiments were carried out for 24 hours using FAs in the 0-200 μM concentration range. These concentration are below or within the reported circulating FA range-see, for example, Higashiyama et al. 26 The rationale for using a 24-hour stimulation is that epigenetic responses to lipoproteins were observed in THP-1 macrophages, a differentiated version of THP-1 monocytes. 12, 13 In accordance with a similar study of AA-stimulated THP-1 cells, where cell proliferation was scored based on 3 H-thymidine incorporation 27 , FAs did not affect cell proliferation as assessed by cell counting.
Overall, AA and OA elicited distinct responses. AA induced a dose-dependent DNA hypermethylation peaking at the 100 μM dose and amounting to a ~10.5% increase in 5mdC content at 100 μM relative to the 1 μM dose ( Figure 1A) . In turn, OA induced a weaker response, with an overall DNA hypomethylation at 100 μM relative to the 1 μM As an independent validation of the total 5mdC data, we performed an ALUspecific methylation assay. ALUs are an abundant transposon family and have often been used as a surrogate of total 5mdC determination. 28 In accordance with total 5mdC data, AA induced a significant dose-dependent increase in ALU methylation while OA showed a tendency to hypomethylation, although not statistically significant in the 1-100 μM range ( Figure 1C ).
Effects of AA and OA on specific CpG site methylation
To detail genomic regions undergoing FA dose-dependent differential DNA methylation at the CpG level resolution, we analyzed THP-1 monocytes stimulated with 1, 10, or 100 μM AA or OA, using the Infinium HumanMethylation450 BeadChip arrays (450K array). The platform represents >485,000 intergenic and intragenic, non-repeated element CpGs. 29, 30 The rationale for using 100 μM as maximal dose was that it yielded the most divergent effects between the two FAs in the total 5mdC assay.
Unsupervised clustering analysis of 450K array data showed that the FAinduced methylation profiles were more divergent at 100 μM FA dose compared to the relatively similar 1 and 10 μM-dose profiles (Figure 2) , mirroring global 5mdC data (compare with Figure 1A ). Next, we sought evidence for an AA dose-dependent DNA hypermethylation response and an opposite one for OA in 450K array data. We . A minority of AACpGs (6,432 or 11.2%) overlapped with OACpGs, corresponding to 3,722 genes.
Biological significance of AACpGs and OACpGs
Although the AA-and OA-induced differential methylation did not reach genome-wide significance, a substantial number of converging findings support a pathobiological significance for AACpGs and OACpGs.
First, in agreement with global DNA methylation data, a general tendency for AAinduced hypermethylation and OA-induced hypomethylation was observed, i.e., the majority of AACpGs (76.4%) and OACpGs (74.7%) showed dose-dependent hyperand hypo-methylation, respectively (P=6.7x10 -32 , Chi-square test; Figure 3) . Likewise, the compounded weight of hypermethylated AACpGs was higher than the hypomethylated counterparts: the sum of Δβs between 100 and 1 μM AA was 1,661.3
and -408.7 for the two sets, respectively. Conversely, the net effect of OACpGs was hypomethylation, since the sum of Δβs between 100 and 1 μM OA was 381.6 and - Table 1 ). These data suggested a functional divergence between AA and PA on the one hand, and OA on the other hand with respect to DNA methylation.
The analogies between FA-stimulated THP-1 cells and a model of pancreatic inflammation raised the question whether similar coincidences exist within a range of human diseases. To address that issue, we compared AACpGs and OACpGs to the 450K array-based human DNA methylation profiling datasets that were available to date. These datasets covered a wide range of disease typology and conditions, i.e., metabolic diseases (atherosclerosis, obesity, type 2 diabetes) [33] [34] [35] , psychiatric disorders (autism-Brodmann areas 10 and 24 profiling-and schizophrenia) 36, 37 , cancer (leukemia, colorectal carcinoma, hepatocellular carcinoma, blood from breast cancer patients), [38] [39] [40] [41] and aging 42 (Supplementary Table 4 ). The inclusion of the mentioned studies is justified by the general relevance of FAs as suppliers of energy and biologically active metabolites, and their recognized involvement in psychiatric disorders (reviewed in 43 ). In addition, the comparative analysis included 450K arraybased DNA methylation profiles of eight non-diseased tissues. 44 The portion of differentially methylated CpGs identified in each study, that overlapped AACpG or
OACpGs ranged between 12-17%. Furthermore, despite differences in Δβ cut-off between arrays (Supplementary and PA-induced profiles were more similar to each other than to OA-induced profiles.
Furthermore, the former clustered with metabolic disease, aging and autism profiles, whereas cancer, schizophrenia and normal tissue-specific profiles grouped away from Overall, these findings support a broad biological significance and instructive mechanism(s), rather than random seeding, for the overall comparatively small AAand OA-induced DNA methylation profiles.
FA-induced CpG methylation and gene expression
To assess the impact of dose-dependent changes in DNA methylation on gene expression, RNA was extracted from the same cells used to produce 450K array data and analyzed using the Affymetrix Human Exon 1.0 ST platform. To probe for an association between expression and DNA methylation, we focused on AACpGs and
OACpGs that colocalized to exonic regions, i.e., 23,436 and 18,591 CpGs, respectively. Of the latter, we correlated the dose-dependent changes in DNA methylation with the corresponding changes in expression values for each exon probe For example, a 12-week supplementation with AA and DHA in baboons is associated with downregulation of PTPRN2 in the cerebral cortex. 50 Likewise, an association between DNA methylation, a sequence variant of PTPRN2 and islet insulin secretion has also recently been identified. 51 In turn, TNXB is one of the two genes showing population-specific polymorphisms associated with dietary adaption to fat, milk, and meat. 52 These associations, although independent and converging, are not definite proof of causality. Also, the effects of FAs presented here are quantitatively modest, reflecting the 10% or less change in DNA methylation profiles that was detected in response to FA, high-fat diet and exercise. 18, 53, 54 Despite these limitations, the data provide testable hypotheses to better understand the regulation of the DNA methylome by FAs and possibly to improve diet-based strategies to improve human health.
These comparisons offer a number of insights into the pathophysiological relevance of the epigenetic responses to FAs. In the case of human atherosclerosis, we show concordance with two previously published studies. First, the histological grade-associated CpGs 45 are significantly enriched in AACpGs. Second, 16 of the most represented genes across the analyzed DNA methylation profiling studies, are densely hypermethylated in the early stages of the aortic atherosclerosis and display a direction of DNA methylation change that is concordant with the one of AA and PA. 33 In both atherosclerosis and AA-stimulated cells, hypermethylation is prominent within the body of these genes. Taken together, these comparative data suggest that a portion of the DNA hypermethylation that characterizes atherosclerosis in its initial phases and during the progression of the stable vascular lesion 33, 45 Additionally, we show that FA-induced profiles are relatively distant from normal tissuespecific ones. This result is expected, as due to the ubiquitous access of circulating FAs to organs and tissues, it is likely that FAs seed DNA methylation profiles that represent common features of the majority of the organism´s epigenomes. Incidentally, our findings confirm and expand the previous observation that normal blood displays a strikingly unique DNA methylation profile, compared to the other tissues and diseases tested. 44 In addition to all these considerations, it is noteworthy that the specificity of the overlap with a number of published studies constitutes a powerful independent validation of our 450K array-based results.
Pathways linked to -oxidation play a pivotal role in determining FA-related methylation profiles. We show that AA-induced DNA hypermethylation is sensitive to inhibition of FA import to mitochondria and is downstream to PPAR- and SIRT1, two central regulators of FA metabolism and -oxidation. 48 THP-1 monocytes, in contrast to cancer cells in general, rely more on -oxidation than glycolysis for energy production and AA has been shown to be a substrate for -oxidation in THP-1 cells. 58, 59 Both these observations support the effects of -oxidation inhibition in our model system. Indeed, the comparatively small overlap between cancer and FA-induced DNA methylation profiles may be explained by the Warburg effect which states that cancer cells mainly produce ATP from glycolysis even in conditions of hypoxia. 60 Following this logic, the DNA hypomethylation observed in diabetes is a predictable consequence of the defective mitochondrial activity associated with that disease. 61 In general, blockage of the mitochondrial machinery rapidly shifts ATP production to glycolysis to assure cell survival. We assume that such an adaptation takes place in THP-1 cells following exposure to -oxidation inhibitor etomoxir, suggesting that inhibition of AA-induced DNA hypermethylation by etomoxir does not result from reduced ATP supply to chromatin modifiers. On the other hand, the OA-induced hypomethylation response is not affected by these inhibitors. This suggests that the distinct AA and OA-induced methylation profiles might relate to FA-specific differences in -oxidation. Indeed, both in vitro and a recent in-vivo dietary study in humans show that OA relative to other FAs, such as PA and EPA, is a poor substrate of -oxidation [62] [63] [64] , although the opposite has also been reported. 65 Alternatively, the increased levels of specific intermediate -
oxidation products observed in PA-relative to OA-stimulated human skeletal muscle cells could also explain part, or all of, the PA-induced methylation. 62 Although our data contrast with the predominant view that SIRT1 is activated solely in condition of starvation, NAD+ independent SIRT1-mediated upregulation of oxidative metabolism has been reported in several other studies. [66] [67] [68] Finally, the observation that SIRT1
participates in the AA-induced DNA hypermethylation response in MEFs, indicates that the corresponding response observed in THP-1 cells is not a cancerous cell-restricted, p53-and MIR34a-dependent event. 69 The PPAR- specific regulation of AA-induced DNA methylation, presumably reflects the observation that polyunsaturated FAs are more potent activators of PPAR- than PPAR-. 70 The involvement of PPAR-, but not PPAR-, is further supported by the results of the functional annotation analysis of FACpG-harboring genes. SIRT6 can also be activated by long-chain FAs, in particular OA, and contributes to regulation of -oxidation. 71, 72 However, knockdown of SIRT6 in MEFs had no effect on FA-induced changes in DNA methylation.
Our observation that AA and OA participate in shaping metabolic diseasespecific DNA methylomes through -oxidation, PPAR- and sirtuin 1 signaling, has potential implications for diet-oriented therapy and prevention. Indeed, it has been argued that the high-fat, low-carbohydrate ketogenic diet, which is successful in clinical management of patients with inborn errors of metabolism and pharmacoresistant epilepsy, may be beneficial in a much broader range of diseases than previously recognized. 73, 74 Conversely, a low-fat, low-carbohydrate diet can lead to normalization of  cell function and insulin resistance in individuals with type 2 diabetes. 75 However, whether or not a shift in substrate preference toward fat oxidation lowers disease risk is still heavily debated. For example, prolonged dietary administration of the PPAR- agonist WY-14643, is associated with a gradual decreased in global and LINE DNA methylation and hepatocarcinogenesis in mice. 76, 77 Furthermore, the differential tumorigenic responses of xenotransplanted leukemia cells THP-1 or NB4 exposed to either a high-fat or high-carbohydrate diet 78 , underlines the importance of understanding energy metabolism of disease subtypes prior to dietary interventions. with cell culture-grade FA-free BSA (fraction V, FA-free, Sigma no. 820022) to achieve a FA:BSA 6:1 ratio, essentially as described. 81 Typically, 5-6x10 6 cells in 10 ml medium were stimulated with 100x BSA-FA mix in 2% FCS. Exclusion of trypan blue was used as a criterion for viability. The inhibitors etomoxir, GW9662, GW6471, sirtinol, splitomycin or trichostatin A (TSA) were used at the concentrations and experimental conditions reported in previous studies. 82, 83 At least three technical and biological replicates were performed for each experiment, excluding microarray experiments.
Global DNA methylation
DNA was extracted from cultured cells by standard methods (DNeasy system, Qiagen).
For the measurement of global DNA methylation levels, 5-methyl-2'-deoxycytidine (5mdC) and 2'-deoxyguanosine (dG) were determined by an HPLC-based method. 84 Normalized 5mdC levels were calculated as percentage 5mdC/dG. When indicated, global DNA methylation was measured by the MethylFlash system (Epigentek). The assay yielded 5mdC values as percentage of PicoGreen-quantified input DNA (wt/wt).
Each value was multiplied by four to obtain a final value comparable to that obtained by the HPLC-based method. The MethylFlash assay yielded responses to AA and OA in THP-1 monocytes, that were consistent with the ones obtained by the HPLC-based 5mdC quantitation, except for baseline (unstimulated cells) values that were 5% lower (P>0.05, data corresponding to a total of 15 and 21 experiments, respectively).
ALU repeat methylation
ALU element methylation was determined according to Sirivanichsuntorn and collaborators. 28 Briefly, bisulfite-treated DNA was amplified by PCR with the ALUspecific primers AluF: 5'-GGY GYG GTG GTT TAY GTT TGT AA-3' and AluR: 5'-TTA ATA AAA ACR AAA TTT CAC CAT ATT AAC CAA AC-3' as follows: 95°C for 30s, 53°C for 20s (40 cycles), and 72°C for 20s. Subsequently, the 117 bp ALU amplicon was digested overnight at 65°C with TaqI (Invitrogen). The resulting products, ranging between 42 and 117 bp depending on the methylation states of ALU elements, were separated by gel electrophoresis, stained with GelRed and quantified using ImageLab (BioRad).
DNA methylation arrays
To identify targets of FA-induced DNA methylation we used the Infinium HumanMethylation450 BeadChip platform (Illumina). Three biological replicates were pooled in equal proportion for each FA concentration. Pooling effectively averages the data and reduces noise. 85 DNA quality checks, bisulfite modification, hybridization, data normalization with the GenomeStudio software (Illumina) and Beta value calculation were carried out as described elsewhere. 29, 86 SNP-proximal probes and probes with a detection P-value >0.05, i.e., not statistically different from the background, were discarded as reported. 45 The methylation level for each cytosine, expressed as a - 
